Wealth Enhancement Advisory Services LLC Has $17.54 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN

Wealth Enhancement Advisory Services LLC increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 27.2% in the fourth quarter, reaching holdings valued at $17.54 million. Other institutional investors also adjusted their positions in the biopharmaceutical company, reflecting ongoing interest in its stock. Regeneron Pharmaceuticals recently reported strong quarterly earnings and announced an increase in its quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments